Simon Schwörer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Simon Schwörer has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Craig B. Thompson
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, USA
37 shared publications - Carlos Carmona-Fontaine
Center for Genomics and Systems Biology, Department of Biology, New York University, New York City, NY, United States of America
33 shared publications - Charles Ng
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
33 shared publications - Francesco V. Cimino
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York
33 shared publications - Kaloyan M. Tsanov
Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA
33 shared publications - Manon Ros
Center for Genomics and Systems Biology, Department of Biology, New York University, New York, USA
33 shared publications
Latest Publications
- Open Access
A Full Spectrum Fibroblast Profiling Panel Reveals Phenotypic and Metabolic Heterogeneity of Cancer-Associated Fibroblasts at the Single-Cell Level
Cancer-associated fibroblasts (CAFs) exhibit extensive transcriptional and phenotypic heterogeneity and are highly plastic. Routine approaches to resolving CAF heterogeneity at the single-cell and protein levels are lacking, making it difficult to assess changes in CAF state in response to perturbations. Here, we present an optimized 28-marker spectral flow cytometry panel that uses unsupervised clustering to resolve CAF states across in vivo and in vitro models. Using this new fibroblast profiling panel (FPP), we show that LRRC15+ CAFs in murine pancreatic ductal adenocarcinoma are phenotypically distinct from canonical αSMA+ myofibroblasts, rather than representing a subset of this population. We find that marker expression is graded rather than discrete across clusters, indicating that CAF identity spans a continuum rather than fixed states. Metabolic profiling further shows that hypoxic CAFs were enriched for glucose uptake and an inflammatory phenotype. Using in vitro models, we further demonstrate how the FPP can resolve plasticity outcomes. In a 3D organoid co-culture model, direct contact between tumor cells and fibroblasts, but not organoid-derived factors alone, induces a stem-like CAF state also observed in vivo. In 2D, TGFβ and inflammatory/hypoxic stimuli each enrich distinct, pre-existing CAF states rather than generating new ones. These findings establish our FPP as a practical method for resolving fibroblast heterogeneity at the protein level in cancer and beyond.
Open AccessA Full Spectrum Fibroblast Profiling Panel Reveals Phenotypic and Metabolic Heterogeneity of Cancer-Associated Fibroblasts at the Single-Cell Level
Cancer-associated fibroblasts (CAFs) exhibit extensive transcriptional and phenotypic heterogeneity and are highly plastic. Routine approaches to resolving CAF heterogeneity at the single-cell and protein levels are lacking, making it difficult to assess changes in CAF state in response to perturbations. Here, we present an optimized 28-marker spectral flow cytometry panel that uses unsupervised clustering to resolve CAF states across in vivo and in vitro models. Using this new fibroblast profiling panel (FPP), we show that LRRC15+ CAFs in murine pancreatic ductal adenocarcinoma are phenotypically distinct from canonical αSMA+ myofibroblasts, rather than representing a subset of this population. We find that marker expression is graded rather than discrete across clusters, indicating that CAF identity spans a continuum rather than fixed states. Metabolic profiling further shows that hypoxic CAFs were enriched for glucose uptake and an inflammatory phenotype. Using in vitro models, we further demonstrate how the FPP can resolve plasticity outcomes. In a 3D organoid co-culture model, direct contact between tumor cells and fibroblasts, but not organoid-derived factors alone, induces a stem-like CAF state also observed in vivo. In 2D, TGFβ and inflammatory/hypoxic stimuli each enrich distinct, pre-existing CAF states rather than generating new ones. These findings establish our FPP as a practical method for resolving fibroblast heterogeneity at the protein level in cancer and beyond.
- 25 March 2026
- Published by Elsevier in Matrix Biology
- Vol. 146, 102003
Glutamine-dependent changes in fibroblast-derived extracellular matrix dictate cancer cell behavior
- 25 March 2026
- Published by Elsevier in Matrix Biology
- Vol. 146, 102003
Glutamine-dependent changes in fibroblast-derived extracellular matrix dictate cancer cell behavior
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 4, related to Figures 4 and 6
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 4, related to Figures 4 and 6
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 1, related to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 1, related to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 2, related to Figure 2
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 2, related to Figure 2
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 3, related to Figure 3
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell–Derived Cytokines
Supplementary Figure 3, related to Figure 3
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 3, related to Figure 3
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 3, related to Figure 3
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 1, related to Figure 1
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 4, related to Figures 4 and 6
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 4, related to Figures 4 and 6
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 2, related to Figure 2
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
Supplementary Figure 2, related to Figure 2